Competing interests
Johnson & Johnson, of which Janssen, Johnson & Johnson., Johnson & Johnson MEA
GS has received speaker fees from AbbVie, Amgen, Bristol Myers Squibb, Eli Lilly, Gilead, Janssen, Novartis, and UCB.WC and SG are employees of Janssen Research & Development, LLC, and own stock or stock options in Johnson & Johnson, of which Janssen Research & Development, LLC is a wholly owned subsidiary.SDC is an employee of Janssen Scientific Affairs, LLC, and owns stock or stock options in Johnson & Johnson, of which Janssen Scientific Affairs, LLC is a wholly owned subsidiary.MShawi is an employee of Immunology Global Medical Affairs, Janssen Pharmaceutical Companies, a wholly owned subsidiary of Johnson & Johnson, and owns stocks in Johnson & Johnson.FL is an employee of Immunology Global Medical Affairs, Janssen Pharmaceutical Companies, a wholly owned subsidiary of Johnson & Johnson, and owns stock in Johnson & Johnson.MZ is an employee of Janssen Medical Affairs, LLC, and owns stock or stock options in Johnson & Johnson, of which Janssen Medical Affairs, LLC, is a wholly owned subsidiary.MSharaf is an employee of Johnson & Johnson MEA and owns stock or stock options in Johnson & Johnson.LCC has received consultant fees from AbbVie, Amgen, Bristol Myers Squibb, Celgene, Eli Lilly, Gilead, Galapagos, Janssen, MoonLake, Novartis, Pfizer, and UCB; grant/research support from AbbVie, Amgen, Celgene, Eli Lilly, Janssen, Novartis, Pfizer, and UCB; and speaker fees from AbbVie, Amgen, Biogen, Celgene, Eli Lilly, Galapagos, Gilead, GlaxoSmithKline, Janssen, Medac, Novartis, Pfizer, and UCB.SS has received institutional research grants from AbbVie, Amgen (previously Celgene), Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, GlaxoSmithKline, Janssen, and UCB; and speaker fees from AbbVie, Amgen, Biogen, Eli Lilly, GlaxoSmithKline, Janssen, and UCB.